Neoadjuvant chemotherapy for Lauren diffuse-type gastric cancer: Is it necessary?
- 23 March 2026
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (5) , 111767
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82203187)
- Excellent Young Scientists Fund
- National Key Clinical Specialty Discipline Construction Program of China
- Guangzhou Municipal Science and Technology Project (2025A04J5296)
This publication has 28 references indexed in Scilit:
- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 updateCancer Communications, 2024
- Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trialNature Medicine, 2024
- Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?Acta Oncologica, 2023
- Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinomaSurgery, 2021
- Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialThe Lancet Oncology, 2021
- Gastrointestinal cancers in China, the USA, and EuropeGastroenterology Report, 2021
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialThe Lancet, 2019
- Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative studyGastric Cancer, 2017
- A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: “eCura system”American Journal of Gastroenterology, 2017
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006